Insilico Medicine Initiates First-in-Human Study of ISM001-055, a Novel Drug Discovered Using Insilico’s Proprietary End-to-end Artificial Intelligence Platform November 30, 2021
Turnstone Biologics Announces Research Collaboration with Moffitt Cancer Center to Advance Novel TIL Immunotherapies for Solid Tumor Indications November 29, 2021
Adagene Announces FDA Clearance of IND for Phase 1b/2 Trial of Anti-CTLA-4 Monoclonal Antibody ADG116 in Combination Therapy with Anti-PD-1 Antibody Pembrolizumab November 29, 2021
Verve Therapeutics Appoints Allison Dorval, Experienced Financial Executive, as Chief Financial Officer November 29, 2021
Ultragenyx Announces Additional Positive Multi-Year Durability Data from Phase 1/2 AAV Gene Therapy Studies November 29, 2021
Tempest Announces First Patient Dosed with TPST-1495 in Combination with Pembrolizumab November 18, 2021
Owkin becomes ‘unicorn’ with $180m investment from Sanofi and four new collaborative projects November 18, 2021
Orchard Therapeutics Announces New England Journal of Medicine Publication of Interim Proof-of-concept Study Results of OTL-203 for Hurler Syndrome November 18, 2021
WellAir Launches New Air Cleaning Device That Is 99.9% Effective Against Indoor Airborne Pathogens November 17, 2021
Denali Therapeutics Announces Strategic Partner Takeda Exercises Option to Co-Develop and Co-Commercialize DNL593 (PTV:PGRN) November 17, 2021